U.S. market Closed. Opens in 2 days 2 hours 3 minutes

MRVI | Maravai LifeSciences Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue288.94M883.00M799.24M284.10M143.14M123.83M
Cost of Revenue151.34M168.96M140.56M79.65M66.85M60.77M
Gross Profit137.60M714.04M658.68M204.45M76.29M63.07M
Operating Expenses141.80M147.63M115.28M103.55M51.98M45.69M
Selling, General & Admin124.52M129.26M100.06M94.25M48.35M41.19M
Research & Development17.28M18.37M15.22M9.30M3.63M4.50M
Other Operating Expenses-1.34M-358.00K279.00K-7.47M118.00K87.00K
Operating Income-4.20M574.22M554.64M67.60M23.99M16.44M
Other Expenses / Income621.93M-22.74M-23.88M14.10M-29.84M-6.47M
Before Tax Income617.74M551.47M530.76M81.70M-5.85M-16.50M
Income Tax Expenses756.11M60.81M61.52M2.88M-652.00K417.00K
Net Income-119.03M490.66M469.25M76.89M-5.20M-17.73M
Interest Expenses45.89M20.41M30.26M30.74M29.96M27.40M
Basic Shares Outstanding131.92M131.54M114.79M96.65M96.65M88.97M
Diluted Shares Outstanding131.92M255.32M257.80M96.65M96.65M88.97M
EBITDA44.58M568.40M543.67M93.43M48.51M39.81M
EBITDA Margin15.43%64.37%68.02%32.89%33.89%32.15%
EBIT682.97M571.89M561.02M110.51M24.11M10.09M
EBIT Margin236.37%64.77%70.19%38.90%16.84%8.14%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙